FI94632B - Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat - Google Patents

Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat Download PDF

Info

Publication number
FI94632B
FI94632B FI894693A FI894693A FI94632B FI 94632 B FI94632 B FI 94632B FI 894693 A FI894693 A FI 894693A FI 894693 A FI894693 A FI 894693A FI 94632 B FI94632 B FI 94632B
Authority
FI
Finland
Prior art keywords
compound
imidazoline
imidazoline derivative
formula
group
Prior art date
Application number
FI894693A
Other languages
English (en)
Finnish (fi)
Other versions
FI894693A0 (sv
FI94632C (sv
FI894693A (sv
Inventor
Kazuo Matsumoto
Mamoru Suzuki
Kozo Yamamoto
Isao Takata
Yoshio Iwasawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI894693A0 publication Critical patent/FI894693A0/sv
Publication of FI894693A publication Critical patent/FI894693A/sv
Application granted granted Critical
Publication of FI94632B publication Critical patent/FI94632B/sv
Publication of FI94632C publication Critical patent/FI94632C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Claims (3)

1. Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat med formeln: o p
10 NH N r R där R är halogenfenylgrupp, eller dess farmaceutiskt god-15 tagbar sait, kännetecknat därav, att en före-ning med formeln O- CH — CH -O (II) nh2 nh2 eller dess sait och en förening med formeln 25 R-C-OR1 II (m) NH 30 där R avser det samma som ovan och R1 är lägre alkylgrupp, eller dess sait kondenseras, och vid behov omvandlas pro-dukten vidare tili sitt farmaceutiskt godtagbar sait. 35 2. Förfarande enligt patentkravet 1, känneteck nat därav, att man framställer 2-(4-klorfenyl)-4,5-di-fenylimidazolin eller dess farmaceutiskt godtagbar sait. |. 94632
3. Förfarande enligt patentkravet 1 eller 2, känne-t e c k n a t därav, att det framställda imidazolinderiva-tet med formlen (I) har cis-konfiguration.
FI894693A 1988-10-06 1989-10-04 Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat FI94632C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63253391A JPH02101065A (ja) 1988-10-06 1988-10-06 イミダゾリン誘導体及びその製法
JP25339188 1988-10-06

Publications (4)

Publication Number Publication Date
FI894693A0 FI894693A0 (sv) 1989-10-04
FI894693A FI894693A (sv) 1990-04-07
FI94632B true FI94632B (sv) 1995-06-30
FI94632C FI94632C (sv) 1995-10-10

Family

ID=17250719

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894693A FI94632C (sv) 1988-10-06 1989-10-04 Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat

Country Status (17)

Country Link
US (1) US5051441A (sv)
EP (1) EP0363061B1 (sv)
JP (1) JPH02101065A (sv)
KR (1) KR960009570B1 (sv)
CN (1) CN1020096C (sv)
AT (1) ATE78470T1 (sv)
AU (1) AU611827B2 (sv)
CA (1) CA1330997C (sv)
DE (1) DE68902209T2 (sv)
DK (1) DK491489A (sv)
ES (1) ES2052015T3 (sv)
FI (1) FI94632C (sv)
GR (1) GR3005779T3 (sv)
HK (1) HK143095A (sv)
HU (1) HU202211B (sv)
IE (1) IE61924B1 (sv)
IL (1) IL91704A0 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92441A (en) * 1988-12-07 1993-05-13 Tanabe Seiyaku Co Imidazole containing peptides, their preparation and pharmaceutical compositions containing them
GB9020889D0 (en) * 1990-09-25 1990-11-07 May & Baker Ltd New compositions of matter
JP2564380Y2 (ja) * 1993-12-10 1998-03-09 大阪瓦斯株式会社 締付トルク確認継手
DE19540027A1 (de) * 1995-10-27 1997-04-30 Gruenenthal Gmbh Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
KR100426204B1 (ko) * 1998-05-23 2004-06-24 문승자 합성수지판제조방법
US6365616B1 (en) 1998-08-31 2002-04-02 Sentron Medical, Inc. Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
US20020142974A1 (en) * 1998-09-11 2002-10-03 Leonard D. Kohn Immune activation by double-stranded polynucleotides
EP1463501B1 (en) 2001-12-18 2008-06-11 F. Hoffmann-La Roche AG Cis-imidazolines as mdm2 inhibitors
EP1643989B1 (en) * 2003-06-17 2010-04-28 F. Hoffmann-La Roche Ag Cis-imidazolines as mdm2 inhibitors
US7425638B2 (en) 2003-06-17 2008-09-16 Hoffmann-La Roche Inc. Cis-imidazolines
US7132421B2 (en) 2003-06-17 2006-11-07 Hoffmann-La Roche Inc. CIS-imidazoles
ATE414693T1 (de) 2004-05-18 2008-12-15 Hoffmann La Roche Neuartige cis-imidazoline
US7893278B2 (en) 2004-06-17 2011-02-22 Hoffman-La Roche Inc. CIS-imidazolines
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP2130822A1 (en) 2005-12-01 2009-12-09 F. Hoffmann-La Roche AG 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
CN101370799B (zh) 2006-01-18 2012-09-05 霍夫曼-拉罗奇有限公司 作为mdm2抑制剂的顺-4,5-二芳基-2-杂环-咪唑啉
US7625895B2 (en) 2007-04-12 2009-12-01 Hoffmann-Le Roche Inc. Diphenyl-dihydro-imidazopyridinones
CN104710408A (zh) 2007-10-09 2015-06-17 霍夫曼-拉罗奇有限公司 手性顺式-咪唑啉类
US8252942B2 (en) * 2007-10-09 2012-08-28 Board Of Trustees Of Michigan State University Substituted imidazoline compounds
CA2933018C (en) * 2014-01-29 2021-10-26 Toray Industries, Inc. Therapeutic or prophylactic agent for multiple sclerosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH44279A (fr) * 1908-03-09 1909-07-16 Anonima Per Frigorigeni E Moto Appareil pour l'échange de chaleur entre des fluides sous pression
NL296772A (sv) * 1962-03-21
GB1047569A (en) * 1962-10-31 1966-11-09 Du Pont Light-sensitive compositions
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
EP0005219B1 (en) * 1978-04-24 1981-07-22 A/S Dumex (Dumex Ltd.) Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
US4424229A (en) * 1979-04-23 1984-01-03 A/S Dumex (Dumex Ltd.) Fluorine containing 2,4,5-triphenylimidazoles
US4252887A (en) * 1979-08-14 1981-02-24 E. I. Du Pont De Nemours And Company Dimers derived from unsymmetrical 2,4,5-triphenylimidazole compounds as photoinitiators
DE3141063A1 (de) * 1981-10-13 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
GB8906198D0 (en) * 1989-03-17 1989-05-04 Ciba Geigy Ag Compounds

Also Published As

Publication number Publication date
JPH02101065A (ja) 1990-04-12
HK143095A (en) 1995-09-15
IE61924B1 (en) 1994-11-30
HU202211B (en) 1991-02-28
FI894693A0 (sv) 1989-10-04
JPH0581592B2 (sv) 1993-11-15
DK491489D0 (da) 1989-10-05
HU895226D0 (en) 1990-01-28
IL91704A0 (en) 1990-06-10
AU4236889A (en) 1990-04-12
IE892977L (en) 1990-04-06
FI94632C (sv) 1995-10-10
CN1041760A (zh) 1990-05-02
HUT51601A (en) 1990-05-28
GR3005779T3 (sv) 1993-06-07
DK491489A (da) 1990-04-07
EP0363061B1 (en) 1992-07-22
KR900006296A (ko) 1990-05-07
US5051441A (en) 1991-09-24
EP0363061A1 (en) 1990-04-11
DE68902209D1 (de) 1992-08-27
FI894693A (sv) 1990-04-07
DE68902209T2 (de) 1992-12-10
ATE78470T1 (de) 1992-08-15
KR960009570B1 (ko) 1996-07-20
ES2052015T3 (es) 1994-07-01
AU611827B2 (en) 1991-06-20
CA1330997C (en) 1994-07-26
CN1020096C (zh) 1993-03-17

Similar Documents

Publication Publication Date Title
FI94632B (sv) Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat
FI70576B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-(3-amino-2-hydroxipropyl)-2-nitroimidazoler
US9579325B2 (en) Modulators of TNF-α signaling
FI93104B (sv) Analogiförfarande för framställning av terapeutiskt användbara substituerade imidazolylalkylpiperazin- och -diazepinderivat
FI68820C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara amnotiazoler
US6004963A (en) Substituted 2, 4-imidazolidinedione compounds as pharmaceutical active ingredients
NO158419B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
US5001134A (en) Piperidines, processes of preparation and medications containing them
CS249115B2 (en) Method of new imidazolylphenylamides production
AU2001259691A1 (en) Modulators of TNF-alpha signaling
CA1213279A (en) Thiomethylpyridine derivatives, process for the production thereof and medicaments containing them
CS272226B2 (en) Method of new lensofuran-2 ylimidazol derivatives production
US6288230B1 (en) 2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
US4772704A (en) 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
FI57100B (fi) Foerfarande foer framstaellning av en ny tioalkylamin n-(3-tiofenylpropyl)-n-(3,3-difenylpropyl)amin jaemte dess salter med farmakologiska egenskaper
JPH02311479A (ja) キノリン誘導体
JPH02142784A (ja) シクロプロパベンゾチオピラノン化合物
GB2147899A (en) Chemical intermediates derived from cyclobutene

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: TANABE SEIYAKU CO., . LTD.